USFDA inspections to be less disruptive for Indian pharma sector: Report
Indian pharma companies have increasingly de-risked their operations by slowly and steadily increasing sales to non-US markets, says India Ratings and Research.
indian pharma
January 2023
August 2022
July 2022
March 2022
November 2021
October 2021
Sluggish exports to hit pharma revenue growth: CRISIL
The domestic formulations market is expected to grow 7-9% this fiscal.
Indian pharma majors to hit US growth bump in FY23
The revenue growth of about 16 leading Indian pharmaceutical companies is estimated to moderate to 6-7% in FY23, says ICRA.
Russia-Ukraine war: India's pharma, fertiliser firms most vulnerable
Ind-Ra estimates that higher food, fertiliser and oil prices are likely to put pressure on the subsidy allocation by the Indian government.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
Quality issues remain for Indian pharma companies: USFDA
The problems faced by FDA’s investigators in India are similar to those around the world, US Food and Drug Administration spokesperson Jeremy Kahn tells Fortune India.
